Training activity information
Details
Interpret crossmatch data and assign results according to local policies
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Local procedures and national guidelines
- Use of data in relation to the full range of investigations
- Requirements of reports including sources of information, appropriate use of patient records, reference materials and current national/international guidelines
- Local and national legislation, protocols and guidelines for information governance
- Local policies
- The clinical implication of the crossmatch result for the patient
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
What does success look like?
- Identify what is expected of you in relation to accurately interpreting raw crossmatch data (e.g., flow data, cytotoxicity score) and assigning a final result (e.g., compatible/incompatible) in accordance with local policies.
- Consider how the learning outcomes apply, specifically in relation to interpreting test results and practicing in accordance with quality standards.
- Discuss with your training officer to gain clarity of what is expected of you in relation to classifying ambiguous or borderline reactivity, correlating the crossmatch result with antibody data, and documenting the rationale for the final assigned result.
What is your prior experience of this activity?
- Think about what you already know about interpreting flow cytometry histograms or cytotoxicity visual data and understanding the immunological basis of crossmatch reactivity.
- Consider possible challenges you might face during the activity, such as encountering borderline positive results, discrepancies between different crossmatch techniques, or inconsistency between the crossmatch outcome and pre-transplant antibody screening data.
- Recognise the scope of your own practice for this activity i.e. know when you will need to seek advice or help, and from whom. You will need to seek advice from your Training Officer when required, for example if the final crossmatch result is unexpectedly positive and requires urgent confirmation and escalation before the transplant can proceed.
- Acknowledge how you feel about interpreting this final, critical piece of pre-transplant diagnostic evidence.
What do you anticipate you will learn from the experience?
- Consider the specific skills you want to develop, such as systematic review of quality controls or precise application of local policies for classifying ambiguous results.
- Identify the specific insights you hope to gain into how the crossmatch result confirms or modifies the risk profile established by antibody testing.
What additional considerations do you need to make?
- Consult actions identified following previous experiences of complex data interpretation or working with clinical policy guidelines.
- Identify important information you need to consider before embarking on the activity, such as reviewing local policies for assigning crossmatch results, the full patient/donor HLA data, and historical antibody monitoring data.
In action
Is anything unexpected occurring?
- Are you noticing anything surprising or different from what you anticipate whilst interpreting the crossmatch data and assigning results?
- Are you encountering situations such as:
- Crossmatch results showing ambiguous or borderline reactivity that challenges definitive classification as positive or negative?
- The crossmatch result being unexpectedly inconsistent with the pre-transplant HLA antibody screening data?
- Unexpected clinical information (e.g., history of recent desensitisation treatment) suddenly influencing the interpretation policy?
How are you reacting to the unexpected development?
- How is this impacting your actions? For example, are you responding to the situation appropriately? Are you adapting or changing your approach to interpreting the ambiguity?
- Consider the steps you are taking in the moment, such as:
- Immediately consulting local policies or algorithms for classifying ambiguous or borderline crossmatch results
- Systematically comparing the crossmatch data against historical antibody results to explain an inconsistency
- How are you feeling in that moment? For instance, are you finding it difficult to assign a result when the policy is ambiguous? Is it affecting your confidence in assigning the final result independently?
What is the conclusion or outcome?
- Identify how you are working within your scope of practice. For example, are you successfully applying policy to assign a compatible result after reconciling minor data inconsistencies? Or are you needing support because the results are highly ambiguous and require senior clinical review and sign-off before a result can be released?
- What are you learning as a result of the unexpected development? For example, are you mastering the application of local policies to borderline cases? Or gaining insight into the correlation between solid phase antibody testing and cell-based crossmatch results?
On action
What happened?
- Begin by summarising the key steps you took when interpreting crossmatch data and assigning the result.
- Consider specific events, actions, or interactions which felt important, such as how you classified borderline Flow Cytometry shifts or determined the final result (compatible/incompatible) based on local policy criteria.
- Include any ‘reflect-in-action’ moments where you had to adapt to the situation as it unfolded, for instance, immediately correlating an unexpected positive result against historical HLA antibody data or seeking senior input when a result fell into an ambiguous policy zone.
- How did you feel during this experience, e.g., did you feel responsible for the final outcome or challenged by equivocal data?
How has this experience contributed to your developing practice?
- Identify what learning you can take from this experience regarding interpreting crossmatch data and applying local policies. What strengths did you demonstrate, e.g., meticulous adherence to local policy criteria?
- What skills and/or knowledge gaps were evident, e.g., knowledge of the clinical significance of specific MFI shift levels or classifying ambiguous results?
- Compare this experience against previous engagement with similar activities – were any previously identified actions for development achieved? Has your practice improved in interpreting test results?
- Identify any challenges you experienced, such as equivocal results, discrepancy with antibody screening, or needing advice on scope of practice regarding assigning a non-standard result, and how you reacted to this.
What will you take from the experience moving forward?
- Identify the actions or ‘next steps’ you will now take to support the assimilation of what you have learnt, including from any feedback you have received, with regards to enhancing your skills in interpreting crossmatch data and applying local policies.
- What will you do differently next time you approach interpreting crossmatch data, for instance, by proactively documenting the rationale for final assignment, especially in equivocal cases?
- Do you need to practise any aspect of the activity further, such as reviewing standardised algorithms for interpreting borderline crossmatch results or key learning outcomes related to practicing in accordance with quality standards?
Beyond action
Have you revisited the experiences?
- How have your subsequent experiences of interpreting crossmatch data and assigning results since completing this specific training activity led you to revisit your initial approach or decisions during that activity? For example, how a subsequent case involving borderline flow crossmatch reactivity inconsistent with antibody screening forced you to re-evaluate the rigour of your initial interpretation and application of local policies during your first attempt at this training activity.
- Considering what you understand about local policies, the clinical significance of reactivity patterns, and the critical clinical implications now, were the actions or considerations you identified after your initial reflection on this training activity sufficient?
- How have you since implemented or adapted improvements in your interpretation methodology or result assignment consistency based on further learning and experiences? For example, how you proactively reviewed and integrated the local policy for classifying ambiguous T-cell/B-cell crossmatch results based on further learning.
- Has discussing the clinical significance of different crossmatch results or the impact of historical antibodies with colleagues, peers, or supervisors changed how you now view your initial experience in this training activity? For example, how professional storytelling with a senior colleague about a time when a delayed interpretation of a positive result jeopardised transplant timing refined your understanding of the critical nature of rapid data analysis and policy application during result assignment.
How have these experiences impacted upon current practice?
- How has the learning from this initial training activity, in combination with subsequent experiences of crossmatch interpretation, contributed to your overall confidence and competence in accurately interpreting urgent crossmatch data, particularly in preparing for general observed assessments (DOPS or OCEs) related to data interpretation or reporting? For example, how your accumulated ability in rapid data analysis and policy application now enables you to manage urgent interpretation confidently during an assessment.
- How has reflecting back on this specific training activity, combined with everything you’ve learned since, shaped your current approach to crossmatch data interpretation?
- How does this evolved understanding help you identify when crossmatch data is ambiguous or requires expert immunological and clinical interpretation and when this is beyond your scope of practice? For example, how your evolved approach means you now routinely seek expert review immediately when data is inconsistent with antibody screening or suggests a major contraindication, recognising this requires senior pathological input.
- Looking holistically at your training journey, how has this initial crossmatch interpretation experience, revisited with your current perspective, contributed to your development in meeting the learning outcomes related to interpreting test results and practicing in accordance with quality standards? For example, how this foundational experience has supported your development in transferable skills such as application of complex policies and decision-making under pressure that will be valuable in future roles or responsibilities.
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 4 |
Outcome
Interpret test results for the range of techniques performed. |
| # 6 |
Outcome
Practice in accordance with quality and accreditation standards. |